251 related articles for article (PubMed ID: 18582519)
1. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
Rhie GE; Jung HM; Kim BS; Mekalanos JJ
Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
[TBL] [Abstract][Full Text] [Related]
2. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
3. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
Boustanshenas M; Bakhshi B; Ghorbani M
J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
[TBL] [Abstract][Full Text] [Related]
4. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
Sanchez J; Holmgren J
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):481-5. PubMed ID: 2492108
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
6. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
[TBL] [Abstract][Full Text] [Related]
7. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
8. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
[TBL] [Abstract][Full Text] [Related]
9. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
10. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
Jertborn M; Svennerholm AM; Holmgren J
Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
12. Thermal stability of an oral killed-cholera-whole-cell vaccine containing recombinant B-subunit of cholera toxin.
Ahmed ZU; Hoque MM; Rahman AS; Sack RB
Microbiol Immunol; 1994; 38(11):837-42. PubMed ID: 7898381
[TBL] [Abstract][Full Text] [Related]
13. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Expression of CTB in
Choi H; Son S; Lee D; Bae J; Seo E; Kim DW; Kim EJ
J Microbiol Biotechnol; 2023 Jun; 33(6):736-744. PubMed ID: 37072680
[TBL] [Abstract][Full Text] [Related]
15. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum).
Sharma MK; Singh NK; Jani D; Sisodia R; Thungapathra M; Gautam JK; Meena LS; Singh Y; Ghosh A; Tyagi AK; Sharma AK
Plant Cell Rep; 2008 Feb; 27(2):307-18. PubMed ID: 17962948
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
Price GA; Holmes RK
PLoS One; 2012; 7(8):e42434. PubMed ID: 22879984
[TBL] [Abstract][Full Text] [Related]
17. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
Yu X; Ma Q
Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
[TBL] [Abstract][Full Text] [Related]
19. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
